Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Published in:

2016

By:

• Kong, J;
• Chuddy, J;
• Stock, I A;
• Loria, P M;
• Straub, S V;
• Vage, C;
• Cameron, K O;
• Bhattacharya, S K;
• Lapham, K;
• McClure, K F;
• Zhang, Y;
• Jackson, V M

Publication type:

journal article